Chatbot-delivered Theory-based Online Intervention in Increasing Seasonal Influenza Vaccination Uptake Among Children Aged 3-6 Years
A Randomized Controlled Trial Evaluating a Chatbot-delivered Theory-based Online Intervention in Increasing Seasonal Influenza Vaccination Uptake Among Children Aged 3-6 Years
This randomized controlled trial will compare the efficacy of a Chatbot-delivered stage-of-change-tailored online intervention versus a Chatbot-delivered non-stage-of-change-tailored online intervention for mothers in increasing seasonal influenza vaccination uptake of their children aged 3-6 years. Mothers of children aged 3-6 years will be randomized evenly into either the intervention or the control group.
In the intervention group, the Chatbot will assess mothers' stage of change regarding their children's seasonal influenza vaccination uptake and deliver SOC-tailored interventions through WhatsApp every two weeks for four times.
In the control group, the Chatbot will provide a standard and non-stage-of-change-tailored intervention every two weeks for four times.
All participants will complete three telephone surveys at baseline (T0), after completion of the intervention (T1) and three months after T1 (T2).
調査の概要
状態
条件
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：Zixin Wang, PhD
- 電話番号：+852 22528474
- メール：wangzx@cuhk.edu.hk
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Mothers aged ≥18 years with at least one child aged 3-6 years studying in kindergarten in Hong Kong
- Cantonese speaking
- Having smartphone with internet access
- Already having WhatsApp on the smartphone
Exclusion Criteria:
- Blindness or deafness
- The index child has known medical contraindications for seasonal influenza vaccination
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：ヘルスサービス研究
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Intervention group
Participants in the intervention group will receive chatbot-delivered online interventions tailored to their current stage of change regarding their index child's seasonal influenza vaccination.
|
The Chatbot will deliver four intervention sessions tailored to participants' current stage of change regarding their index child's seasonal influenza vaccination uptake at Week 0, 2, 4, and 6.
Participants will also have access to real-time Question-and-Answer (QA) function provided by the chatbot to address their questions related to seasonal influenza vaccination during the intervention period (week 0-6), and they are free to spend as much time as they want on such function.
|
|
アクティブコンパレータ：Control group
Participants in the control group will receive chatbot-delivered standard and non-stage-of-change-tailored interventions
|
The Chatbot will automatically send participants a link to access a standard online video at week 0, 2, 4 and 6.
Participants will also have access to real-time Question-and-Answer (QA) function provided by the chatbot to address their questions related to seasonal influenza vaccination during the intervention period (week 0-6), and they are free to spend as much time as they want on such function.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Index child's seasonal influenza vaccination uptake reported by his/her mother with validation
時間枠：3 months after completion of the interventions (T2)
|
The research team will ask the participants whether their index children have taken up seasonal influenza vaccination at T2 (3 months after completion of the interventions) using a validated question through telephone interview.
The research team will validate the outcome by requesting participants uploading an image of SIV receipt, while hiding personal identification, via the WhatsApp account used in this project.
|
3 months after completion of the interventions (T2)
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- HMRF24230092
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。